Table 2.
Diameter of the inhibition zone (mm) of Tris and warm aqueous protein extract of Auricularia auricula-judae against studied pathogens.
| Studied pathogen | Tris buffer protein extract | Warm aqueous protein extract | Ciprofloxacin (5 μg/mL) | Fluconazole (12 μg/mL) |
|---|---|---|---|---|
| Staphylococcus aureus | 3.66 ± 0.53 | 3.66 ± 0.53 | 8.66 ± 0.65 | – |
| Escherichia coli | 6.00 ± 0.00 | 3.66 ± 0.53 | 8.33 ± 0.65 | – |
| Pseudomonas aeruginosa | 4.00 ± 0.00 | 2.66 ± 0.65 | 8.33 ± 0.65 | – |
| Klebsiella pneumoniae | 2.33 ± 0.65 | 2.33 ± 0.65 | 7.66 ± 0.65 | – |
| Bacillus subtilis | 3.00 ± 0.00 | 3.00 ± 0.00 | 6.33 ± 0.65 | – |
| Candida albicans | 3.33 ± 0.65 | 1.66 ± 0.65 | – | 7.00 ± 0.00 |
| Trichophyton schoenleinii | 2.33 ± 0.65 | 2.00 ± 0.00 | – | 6.66 ± 0.65 |
| Trichophyton mentagrophytes | 0.00 ± 0.00 | 0.00 ± 0.00 | – | 5.66 ± 0.65 |
| Microsporum gypseum | 0.00 ± 0.00 | 0.00 ± 0.00 | – | 7.33 ± 0.65 |
| Microsporum ferugineum | 0.00 ± 0.00 | 0.00 ± 0.00 | – | 6.33 ± 0.65 |